Search

Ricky D Shafer

Examiner (ID: 1251)

Most Active Art Unit
2872
Art Unit(s)
2507, 2872
Total Applications
2439
Issued Applications
1744
Pending Applications
164
Abandoned Applications
501

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1022036 [patent_doc_number] => 06887977 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Methods and materials relating to CD8-tropic HIV-1' [patent_app_type] => utility [patent_app_number] => 10/040802 [patent_app_country] => US [patent_app_date] => 2001-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9151 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887977.pdf [firstpage_image] =>[orig_patent_app_number] => 10040802 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/040802
Methods and materials relating to CD8-tropic HIV-1 Dec 27, 2001 Issued
Array ( [id] => 6869831 [patent_doc_number] => 20030082520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Procedure for quantitative determination of viral particles having a cholesterol-containing envelope' [patent_app_type] => new [patent_app_number] => 10/033041 [patent_app_country] => US [patent_app_date] => 2001-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2750 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082520.pdf [firstpage_image] =>[orig_patent_app_number] => 10033041 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/033041
Procedure for quantitative determination of viral particles having a cholesterol-containing envelope Dec 26, 2001 Abandoned
Array ( [id] => 1253824 [patent_doc_number] => 06670466 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-30 [patent_title] => 'Human endogenous retrovirus in breast cancer' [patent_app_type] => B1 [patent_app_number] => 10/018865 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 14369 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670466.pdf [firstpage_image] =>[orig_patent_app_number] => 10018865 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/018865
Human endogenous retrovirus in breast cancer Dec 18, 2001 Issued
Array ( [id] => 6534536 [patent_doc_number] => 20020137025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Method and system for anonymously testing for a human malady' [patent_app_type] => new [patent_app_number] => 10/015133 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8444 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137025.pdf [firstpage_image] =>[orig_patent_app_number] => 10015133 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/015133
Method and system for anonymously testing for a human malady Dec 10, 2001 Abandoned
Array ( [id] => 1285445 [patent_doc_number] => 06635246 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Inactivated influenza virus vaccine for nasal or oral application' [patent_app_type] => B1 [patent_app_number] => 09/913400 [patent_app_country] => US [patent_app_date] => 2001-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3789 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635246.pdf [firstpage_image] =>[orig_patent_app_number] => 09913400 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/913400
Inactivated influenza virus vaccine for nasal or oral application Dec 4, 2001 Issued
10/012212 Ligands to enhance specific cellular uptake of biomolecules Nov 29, 2001 Abandoned
Array ( [id] => 1261059 [patent_doc_number] => 06664042 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Determining viral load in double negative T cells' [patent_app_type] => B1 [patent_app_number] => 09/890010 [patent_app_country] => US [patent_app_date] => 2001-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 28 [patent_no_of_words] => 13021 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664042.pdf [firstpage_image] =>[orig_patent_app_number] => 09890010 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/890010
Determining viral load in double negative T cells Nov 22, 2001 Issued
Array ( [id] => 6778192 [patent_doc_number] => 20030049273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin' [patent_app_type] => new [patent_app_number] => 10/050875 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24104 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049273.pdf [firstpage_image] =>[orig_patent_app_number] => 10050875 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/050875
Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin Nov 19, 2001 Issued
Array ( [id] => 6377144 [patent_doc_number] => 20020119444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistance' [patent_app_type] => new [patent_app_number] => 09/988010 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7982 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119444.pdf [firstpage_image] =>[orig_patent_app_number] => 09988010 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/988010
Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistance Nov 15, 2001 Issued
Array ( [id] => 6429106 [patent_doc_number] => 20020127207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Compositions and methods for reducing the amount of salmonella in livestock' [patent_app_type] => new [patent_app_number] => 09/986419 [patent_app_country] => US [patent_app_date] => 2001-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5446 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127207.pdf [firstpage_image] =>[orig_patent_app_number] => 09986419 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/986419
Compositions and methods for reducing the amount of salmonella in livestock Nov 7, 2001 Issued
Array ( [id] => 1342679 [patent_doc_number] => 06582697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-24 [patent_title] => 'Enhancement of the cellular immune response' [patent_app_type] => B2 [patent_app_number] => 09/986049 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3311 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582697.pdf [firstpage_image] =>[orig_patent_app_number] => 09986049 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/986049
Enhancement of the cellular immune response Nov 6, 2001 Issued
Array ( [id] => 6744975 [patent_doc_number] => 20030022158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus' [patent_app_type] => new [patent_app_number] => 09/992896 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10762 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022158.pdf [firstpage_image] =>[orig_patent_app_number] => 09992896 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/992896
Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus Nov 4, 2001 Abandoned
Array ( [id] => 5873794 [patent_doc_number] => 20020048748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Methods of therapy for HIV infection' [patent_app_type] => new [patent_app_number] => 09/974470 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10220 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048748.pdf [firstpage_image] =>[orig_patent_app_number] => 09974470 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/974470
Methods of therapy for HIV infection Oct 8, 2001 Issued
Array ( [id] => 793043 [patent_doc_number] => 06982088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-03 [patent_title] => 'Vaccine composition and stabilization method using high molecular weight PVP' [patent_app_type] => utility [patent_app_number] => 10/381948 [patent_app_country] => US [patent_app_date] => 2001-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2487 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982088.pdf [firstpage_image] =>[orig_patent_app_number] => 10381948 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/381948
Vaccine composition and stabilization method using high molecular weight PVP Oct 7, 2001 Issued
Array ( [id] => 5814233 [patent_doc_number] => 20020039570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases' [patent_app_type] => new [patent_app_number] => 09/969866 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4694 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20020039570.pdf [firstpage_image] =>[orig_patent_app_number] => 09969866 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/969866
Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases Oct 3, 2001 Abandoned
Array ( [id] => 6817698 [patent_doc_number] => 20030068656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Test strip for detecting gastric problems based on the presence of urease' [patent_app_type] => new [patent_app_number] => 09/970415 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4185 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068656.pdf [firstpage_image] =>[orig_patent_app_number] => 09970415 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/970415
Test strip for detecting gastric problems based on the presence of urease Oct 1, 2001 Issued
Array ( [id] => 6327025 [patent_doc_number] => 20020197734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients' [patent_app_type] => new [patent_app_number] => 09/963064 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13674 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197734.pdf [firstpage_image] =>[orig_patent_app_number] => 09963064 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/963064
Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients Sep 24, 2001 Issued
Array ( [id] => 6017617 [patent_doc_number] => 20020103344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Glycoprotein mutants of retrovirus envelopes and their biological applications' [patent_app_type] => new [patent_app_number] => 09/960653 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7299 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103344.pdf [firstpage_image] =>[orig_patent_app_number] => 09960653 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/960653
Glycoprotein mutants of retrovirus envelopes and their biological applications Sep 23, 2001 Abandoned
Array ( [id] => 6624893 [patent_doc_number] => 20020086283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Immunogen' [patent_app_type] => new [patent_app_number] => 09/960717 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 9375 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086283.pdf [firstpage_image] =>[orig_patent_app_number] => 09960717 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/960717
Immunogen comprising an HIV envelope protein, a ligand and H2 peptide Sep 23, 2001 Issued
09/913525 VACCINE COMPOSITIONS AGAINST INFECTIOUS PATHOLOGIES FOR MAMMALS Sep 11, 2001 Abandoned
Menu